JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

China flag China · Delayed Price · Currency is CNY
26.35
-0.03 (-0.11%)
At close: Apr 29, 2026
-5.22%
Market Cap 11.48B
Revenue (ttm) 2.35B
Net Income (ttm) 591.58M
Shares Out 435.17M
EPS (ttm) 1.35
PE Ratio 19.54
Forward PE n/a
Dividend 0.55 (2.08%)
Ex-Dividend Date Jun 17, 2025
Volume 524,203
Average Volume 635,214
Open 26.59
Previous Close 26.38
Day's Range 26.12 - 26.59
52-Week Range 25.63 - 30.02
Beta 0.40
RSI 44.32
Earnings Date Apr 24, 2026

About SHA:603235

JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, α-acetyl-γ-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China. [Read more]

Industry Packaged Foods
Founded 2004
Employees 2,679
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603235
Full Company Profile

Financial Performance

In 2025, SHA:603235's revenue was 2.35 billion, an increase of 6.18% compared to the previous year's 2.21 billion. Earnings were 591.58 million, a decrease of -9.16%.

Financial Statements

News

There is no news available yet.